Diisopropylethylamine → N-[1-(2,3-dichlorobenzyl)pyrrolidin-3-(RS)-ylmethyl]-2-[5-(4-methoxyphenyl)pyrimidin-2-ylamino]acetamide HCl salt
Reaction equation
Cl.C[N:3](C)[CH2:4][CH2:5][CH2:6][N:7]=[C:8]=[N:9][CH2:10][CH3:11].[NH2:13][CH2:14][CH:15]1[CH2:19][CH2:18][N:17]([CH2:20][C:21]2[CH:26]=[CH:25][CH:24]=[C:23]([Cl:27])[C:22]=2[Cl:28])[CH2:16]1.[CH3:29][O:30][C:31]1[CH:32]=[C:33](C2C=NC(NCC(O)=O)=NC=2)[CH:34]=[CH:35][CH:36]=1.O.[OH:49]N1C2C=CC=CC=2N=N1.C(N(C(C)C)CC)(C)C>CN(C)C=O>[ClH:27].[Cl:28][C:22]1[C:23]([Cl:27])=[CH:24][CH:25]=[CH:26][C:21]=1[CH2:20][N:17]1[CH2:18][CH2:19][CH:15]([CH2:14][NH:13][C:11](=[O:49])[CH2:10][NH:9][C:8]2[N:3]=[CH:4][C:5]([C:34]3[CH:33]=[CH:32][C:31]([O:30][CH3:29])=[CH:36][CH:35]=3)=[CH:6][N:7]=2)[CH2:16]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
Solid 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (14 mg, 0.08 mmol, 1.5 equiv.) was added to a solution of 3-(RS)-aminomethyl-1-(2,3-dichlorobenzyl)-pyrrolidine (13 mg, 0.05 mmol), 2-[5-(3-methoxyphenyl)pyrimidin-2-ylamino]acetic acid (16 mg, 0.06 mmol, 1.2 equiv.), 1-hydroxybenzotriazole hydrate (10 mg, 0.08 mmol, 1.5 equiv.) and diisopropylethylamine (22 mL, 0.13 mmol, 2.5 equiv.) in dimethyl formamide (0.5 mL). The reaction mixture was shaken at room temperature overnight. The reaction mixture was quenched with methanol (0.3 mL), then purified directly by reverse phase preparative HPLC to give N-[1-(2,3-dichlorobenzyl)pyrrolidin-3-(RS)-ylmethyl]-2-[5-(4-methoxyphenyl)pyrimidin-2-ylamino]acetamide HCl salt (11 mg).
Workup
- customThe reaction mixture was quenched with methanol (0.3 mL)
- custompurified directly by reverse phase preparative HPLC
Sources & evidence
- ORD record
- ord-740fe55dfa3c4979a8078e1ec715cece
- Source dataset
- uspto-grants-2000_12
- Patent number
- US06166015
Reaction notes
Loading…